Psilocybe weraroa
| Psilocybe weraroa | |
|---|---|
| Scientific classification | |
| Kingdom: | Fungi |
| Division: | Basidiomycota |
| Class: | Agaricomycetes |
| Order: | Agaricales |
| Family: | Hymenogastraceae |
| Genus: | Psilocybe |
| Species: | P. weraroa |
| Binomial name | |
| Psilocybe weraroa Borovička, Oborník & Noordel. (2011) | |
| Synonyms | |
|
Secotium novae-zelandiae G.Cunn. (1924) | |
| Psilocybe weraroa | |
|---|---|
| Mycological characteristics | |
| Glebal hymenium | |
| Cap is conical or ovate | |
| Hymenium attachment is not applicable | |
| Stipe is bare or has a cortina | |
| Spore print is purple-brown | |
| Ecology is saprotrophic | |
| Edibility is psychoactive | |
Psilocybe weraroa, formerly Weraroa novae-zelandiae, is a secotioid fungus in the family Hymenogastraceae. It is endemic to New Zealand, where it grows in native forests from rotting wood and woody debris. Despite its pouch-like form this species is closely related to Psilocybe cyanescens and Psilocybe subaeruginosa. As a bluing member of the genus Psilocybe it contains the psychoactive compounds psilocin and psilocybin. It has been cultivated commercially by Rua Bioscience with a view to researching potential medical applications, bringing together Rongoā Māori with the recent interest in Western medicine in the medical applications of psilocin and psilocybin.